Interdialytic Hypertension-An Update

Advances in Chronic Kidney Disease

Volumn 18, Issue 1, 2011, Pages 11-16

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory BP monitoring; Diagnosis; Hemodialysis; Home BP monitoring; Hypertension; Pathophysiology; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; DARUSENTAN; DECONGESTIVE AGENT; DIHYDROPYRIDINE CALCIUM BLOCKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CLINICAL EFFECTIVENESS; DIALYSATE; DRUG EFFICACY; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FAILURE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BLOOD PRESSURE MONITORING, AMBULATORY; BLOOD VOLUME; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 78651089986     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.10.001     Document Type: Review

References (62)

1. Plantinga L.C., Miller E.R., Stevens L.A., et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension 2009, 54:47-56.
2. Sarafidis P.A., Li S., Chen S.C., et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008, 121:332-340.
3. Agarwal R., Nissenson A.R., Batlle D., et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003, 115:291-297.
4. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial 2002, 15:299-304.
5. Kelley K., Light R.P., Agarwal R. Trended cosinor change model for analyzing hemodynamic rhythm patterns in hemodialysis patients. Hypertension 2007, 50:143-150.
6. Agarwal R. Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension 2009, 54:241-247.
7. Agarwal R. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring. Curr Opin Nephrol Hypertens 2006, 15:309-313.
8. Agarwal R., Andersen M.J., Bishu K., et al. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 2006, 69:900-906.
9. Agarwal R., Brim N.J., Mahenthiran J., et al. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 2006, 47:62-68.
10. Alborzi P., Patel N., Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2007, 2:1228-1234.
11. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010, 55:762-768.
12. Agarwal R. Managing hypertension using home blood pressure monitoring among haemodialysis patients-a call to action. Nephrol Dial Transplant 2010, 25:1766-1771.
13. Agarwal R., Satyan S., Alborzi P., et al. Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 2009, 30:126-134.
14. Pickering T.G., Miller N.H., Ogedegbe G., et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008, 52:10-29.
15. Agarwal R., Light R.P. Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Am J Kidney Dis 2009, 54:693-701.
16. Agarwal R., Andersen M.J., Light R.P. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol 2007, 28:210-217.
17. Agarwal R., Peixoto A.J., Santos S.F., et al. Pre and post dialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006, 1:389-398.
18. Rohrscheib M.R., Myers O.B., Servilla K.S., et al. Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol 2008, 3:1407-1414.
19. Agarwal R., Metiku T., Tegegne G.G., et al. Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol 2008, 3:1364-1372.
20. Agarwal R., Light R.P. Median intradialytic blood pressure can track changes evoked by probing dry-weight. Clin J Am Soc Nephrol 2010, 5:897-904.
21. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005, 45:S1-S153.
22. Davenport A., Cox C., Thuraisingham R. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 2007, 73:759-764.
23. Agarwal R., Andersen M.J., Pratt J.H. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 2008, 3:153-158.
24. Machnik A., Neuhofer W., Jantsch J., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15:545-552.
25. Converse R.L., Jacobsen T.N., Toto R.D., et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992, 327:1912-1918.
26. Hansen J., Victor R.G. Direct measurements of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens 1994, 3:636-643.
27. Xu J., Li G., Wang P., et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005, 115:1275-1280.
28. Agarwal R. Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int 1999, 55:1528-1535.
29. Maggiore Q., Biagini M., Zoccali C., et al. Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients. Clin Sci Mol Med Suppl 1975, 2:73s-75s.
30. Rosansky S.J., Johnson K.L., McConnel J. Use of transdermal clonidine in chronic hemodialysis patients. Clin Nephrol 1993, 39:32-36.
31. Agarwal R., Lewis R.R., Davis J.L., et al. Lisinopril therapy for hemodialysis hypertension-hemodynamic and endocrine responses. Am J Kidney Dis 2001, 38:1245-1250.
32. Zoccali C., Mallamaci F., Maas R., et al. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 2002, 62:339-345.
33. Erkan E., Devarajan P., Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis 2002, 40:76-81.
34. Weber M.A., Black H., Bakris G., et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 374:1423-1431.
35. Morfis L., Smerdely P., Howes L.G. Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens 1997, 15:1271-1276.
36. Ifudu O., Matthew J.J., Macey L.J., et al. Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am J Nephrol 1998, 18:28-34.
37. Krapf R., Hulter H.N. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 2009, 4:470-480.
38. Muntzel M., Hannedouche T., Lacour B., et al. Erythropoietin increases blood pressure in normotensive and hypertensive rats. Nephron 1993, 65:601-604.
39. Schmieder R.E., Langenfeld M.R., Hilgers K.F. Endogenous erythropoietin correlates with blood pressure in essential hypertension. Am J Kidney Dis 1997, 29:376-382.
40. Jones M.A., Kingswood J.C., Dallyn P.E., et al. Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension. Clin Nephrol 1995, 44:193-200.
41. Kaupke C.J., Kim S., Vaziri N.D. Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J Am Soc Nephrol 1994, 4:1874-1878.
42. Vaziri N.D., Zhou X.J., Naqvi F., et al. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am J Physiol 1996, 271:E113-E122.
43. Inscho E.W., Cook A.K., Mui V., et al. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension 1998, 31:421-428.
44. Erne P., Bolli P., Burgisser E., et al. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 1984, 310:1084-1088.
45. Tepel M., Wischniowski H., Zidek W. Erythropoietin induced transmembrane calcium influx in essential hypertension. Life Sci 1992, 51:161-167.
46. Ruschitzka F.T., Wenger R.H., Stallmach T., et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A 2000, 97:11609-11613.
47. Pannier B., Guerin A.P., Marchais S.J., et al. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005, 45:592-596.
48. Iliescu E.A., Yeates K.E., Holland D.C. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant 2004, 19:95-99.
49. Agarwal R., Light R.P. Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol 2007, 294:F303-F308.
50. Agarwal R., Alborzi P., Satyan S., Light R.P. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009, 53:500-507.
51. Agarwal R., Kelley K., Light R.P. Diagnostic utility of blood volume monitoring in hemodialysis patients. Am J Kidney Dis 2008, 51:242-254.
52. Rodriguez H.J., Domenici R., Diroll A., et al. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int 2005, 68:854-861.
53. Goldstein S.L., Smith C.M., Currier H. Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol 2003, 14:2127-2131.
54. Patel H.P., Goldstein S.L., Mahan J.D., et al. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol 2007, 2:252-257.
55. Law M.R., Frost C.D., Wald N.J. By how much does dietary salt reduction lower blood pressure? III-analysis of data from trials of salt reduction. BMJ 1991, 302:819-824.
56. de Paula F.M., Peixoto A.J., Pinto L.V., et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004, 66:1232-1238.
57. Heerspink H.J., Ninomiya T., Zoungas S., et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009, 373:1009-1015.
58. Agarwal R., Sinha A.D. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension 2009, 53:860-866.
59. Fagugli R.M., Pasini P., Quintaliani G., et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant 2003, 18:2332-2338.
60. Walsh M., Culleton B., Tonelli M., et al. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 2005, 67:1500-1508.
61. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007, 298:1291-1299.
62. Agarwal R., Peixoto A.J., Santos S.F., et al. Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 2009, 14:2-11.